Related Experiment Video
Updated: May 9, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
GET3 regulates apoptosis via tail-anchoring of MCL1
Chun Yin Yu1, Mingxuan Du1, Tsz Kwan Yeung1
1Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
Abstract:
The BCL2-like protein MCL1 plays pivotal roles in apoptosis and non-apoptotic functions. While many BCL2 family members are predicted to be tail-anchored (TA) proteins, direct evidence for MCL1's membrane targeting via the GET pathway, a major pathway for membrane insertion of TA proteins, has been lacking. Using degron-mediated depletion of GET3 (ASNA1/TRC40) in human cell lines, we uncovered a role of GET3 in regulating apoptosis. Depleting GET3 induced a slowdown of the cell cycle in HeLa and non-cancerous RPE1 cells. However, GET3 deficiency induced a more pronounced toxicity in HeLa cells, marked by enhanced apoptosis and reduced clonogenic survival. Notably, MCL1 expression diminished upon GET3 depletion and increased with GET3 overexpression, suggesting that MCL1 may be a TA-containing cargo of GET3. Moreover, we observed a direct interaction between GET3 and MCL1 via the C-terminal hydrophobic tail. Functionally, GET3 depletion enhanced apoptosis triggered by pharmaceutical inhibition of MCL1. Furthermore, GET3 deficiency promoted MCL1 downregulation and accelerated apoptosis during prolonged mitotic arrest. These findings underscore the importance of the GET pathway in regulating apoptosis and MCL1's tail-anchoring.
Insights
The GET pathway regulates apoptosis by controlling MCL1, a key protein. GET3 depletion impacts cell cycle and survival, highlighting MCL1
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The BCL2-like protein MCL1 is crucial for apoptosis and other cellular functions.
- Many BCL2 family proteins are tail-anchored (TA) proteins, but MCL1's membrane targeting mechanism is unclear.
- The Guided Entry (GET) pathway is a primary route for TA protein membrane insertion.
Purpose of the Study:
- To investigate the role of the GET pathway, specifically GET3 (ASNA1/TRC40), in regulating MCL1 and apoptosis.
- To determine if MCL1 is a tail-anchored cargo of the GET pathway.
- To elucidate the functional consequences of GET3 deficiency on cell cycle, apoptosis, and survival.
Main Methods:
- Utilized degron-mediated depletion of GET3 in human cell lines (HeLa and RPE1).
- Assessed cell cycle progression, apoptosis markers, and clonogenic survival.
- Performed co-immunoprecipitation to detect interactions between GET3 and MCL1.
- Investigated MCL1 expression levels under GET3 depletion and overexpression conditions.
Main Results:
- GET3 depletion caused cell cycle arrest in HeLa and RPE1 cells.
- GET3 deficiency led to increased apoptosis and reduced survival, particularly in HeLa cells.
- MCL1 expression decreased with GET3 depletion and increased with GET3 overexpression, indicating MCL1 is a GET3 cargo.
- Direct interaction between GET3 and MCL1's C-terminal tail was confirmed.
- GET3 depletion exacerbated apoptosis induced by MCL1 inhibitors and prolonged mitotic arrest.
Conclusions:
- The GET pathway, via GET3, plays a significant role in regulating apoptosis.
- MCL1 is a tail-anchored protein targeted by the GET pathway.
- GET3 deficiency sensitizes cells to apoptosis, especially under stress conditions involving MCL1 inhibition or mitotic arrest.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Tail-anchoring of Proteins in the ER Membrane
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Abnormal Proliferation

